Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVGR NASDAQ:CLGN NASDAQ:HSCS NYSE:RBOT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVGRAvinger$0.47$0.47$0.36▼$1.93$1.57M1.291.46 million shsN/ACLGNCollPlant Biotechnologies$0.42-2.7%$0.46$0.27▼$4.98$5.98M1.4789,595 shs7,430 shsHSCSHeartSciences$1.93-2.5%$2.15$1.77▼$6.47$6.14M2.0322,021 shs23,489 shsRBOTVicarious Surgical$0.96-3.3%$0.74$0.27▼$13.75$6.84M1.4978,202 shs31,762 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVGRAvinger0.00%0.00%0.00%0.00%0.00%CLGNCollPlant Biotechnologies0.00%-1.93%+2.50%-31.11%-77.91%HSCSHeartSciences0.00%+6.45%-3.41%-29.54%-50.00%RBOTVicarious Surgical0.00%+24.11%+80.53%-50.97%-85.13%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVGRAvinger$0.47$0.47$0.36▼$1.93$1.57M1.291.46 million shsN/ACLGNCollPlant Biotechnologies$0.42-2.7%$0.46$0.27▼$4.98$5.98M1.4789,595 shs7,430 shsHSCSHeartSciences$1.93-2.5%$2.15$1.77▼$6.47$6.14M2.0322,021 shs23,489 shsRBOTVicarious Surgical$0.96-3.3%$0.74$0.27▼$13.75$6.84M1.4978,202 shs31,762 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVGRAvinger0.00%0.00%0.00%0.00%0.00%CLGNCollPlant Biotechnologies0.00%-1.93%+2.50%-31.11%-77.91%HSCSHeartSciences0.00%+6.45%-3.41%-29.54%-50.00%RBOTVicarious Surgical0.00%+24.11%+80.53%-50.97%-85.13%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVGRAvinger 0.00N/AN/AN/ACLGNCollPlant Biotechnologies 2.00Hold$11.502,671.08% UpsideHSCSHeartSciences 2.00Hold$8.00314.51% UpsideRBOTVicarious Surgical 1.67Reduce$7.00629.17% UpsideCurrent Analyst Ratings BreakdownLatest AVGR, RBOT, CLGN, and HSCS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026CLGNCollPlant Biotechnologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)4/20/2026CLGNCollPlant Biotechnologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026HSCSHeartSciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/24/2026HSCSHeartSciences Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.00 ➝ $8.00(Data available from 5/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVGRAvinger$7.65M0.21N/AN/A($4.53) per share-0.10CLGNCollPlant Biotechnologies$2.37M2.52N/AN/A$0.48 per share0.86HSCSHeartSciencesN/AN/AN/AN/A$0.18 per shareN/ARBOTVicarious SurgicalN/AN/AN/AN/A$7.89 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVGRAvinger-$18.32M-$11.06N/AN/AN/AN/AN/AN/AN/ACLGNCollPlant Biotechnologies-$11.49M-$1.35N/AN/AN/A-353.70%-161.69%-109.44%5/26/2026 (Estimated)HSCSHeartSciences-$8.77M-$4.94N/AN/AN/AN/A-333.50%-140.18%7/23/2026 (Estimated)RBOTVicarious Surgical-$63.22M-$6.69N/AN/AN/AN/A-184.13%-112.50%7/30/2026 (Estimated)Latest AVGR, RBOT, CLGN, and HSCS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/26/2026Q1 2026CLGNCollPlant Biotechnologies-$0.2374N/AN/AN/A$0.46 millionN/A3/16/2026Q3 2026HSCSHeartSciences-$0.84-$0.63+$0.21-$0.63N/AN/A3/9/2026Q4 2025RBOTVicarious Surgical-$1.37-$1.65-$0.28-$1.73N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAVGRAvingerN/AN/AN/AN/AN/ACLGNCollPlant BiotechnologiesN/AN/AN/AN/AN/AHSCSHeartSciencesN/AN/AN/AN/AN/ARBOTVicarious SurgicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVGRAvingerN/AN/AN/ACLGNCollPlant BiotechnologiesN/A2.532.31HSCSHeartSciences0.161.191.04RBOTVicarious SurgicalN/A4.754.75Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVGRAvinger18.30%CLGNCollPlant Biotechnologies21.69%HSCSHeartSciences17.24%RBOTVicarious Surgical47.27%Insider OwnershipCompanyInsider OwnershipAVGRAvinger42.80%CLGNCollPlant Biotechnologies9.60%HSCSHeartSciences4.90%RBOTVicarious Surgical9.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVGRAvinger703.31 million1.89 millionNot OptionableCLGNCollPlant Biotechnologies7014.41 million13.03 millionOptionableHSCSHeartSciences103.18 million3.03 millionNot OptionableRBOTVicarious Surgical2107.12 million5.89 millionNo DataAVGR, RBOT, CLGN, and HSCS HeadlinesRecent News About These CompaniesVicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical SettingMay 13, 2026 | globenewswire.comVicarious Surgical Reports First Quarter 2026 Financial ResultsApril 30, 2026 | globenewswire.comVicarious Surgical Shareholders Approve Reverse Stock Split AuthorizationApril 8, 2026 | tipranks.comVicarious Surgical, Inc. Class AApril 7, 2026 | edition.cnn.comVicarious Surgical completes testing milestone for surgical robotMarch 30, 2026 | massdevice.comVicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia RepairMarch 30, 2026 | globenewswire.comVicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq ListingMarch 25, 2026 | globenewswire.com‘Why do we exist?’: Inside Stephen From’s business strategy to get Vicarious Surgical to the finish lineMarch 20, 2026 | massdevice.comVicarious Fights to Stay Afloat & Other Medtech NewsMarch 19, 2026 | mddionline.comMThis surgical robotics company sees opportunity in hernia repairMarch 19, 2026 | medicaldesignandoutsourcing.comMVicarious Surgical pursues Nasdaq listing, cuts cash burn to $19MMarch 16, 2026 | massdevice.comVicarious Surgical applies for Nasdaq listingMarch 16, 2026 | medtechdive.comMVicarious Fights to Right the ShipMarch 16, 2026 | mddionline.comMVicarious Surgical Announces Strategic Plan to Pursue Nasdaq ListingMarch 16, 2026 | uk.finance.yahoo.comVicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial ResultsMarch 9, 2026 | businesswire.comVicarious Surgical Implements Executive Salary Reductions, Maintains IncentivesMarch 6, 2026 | tipranks.comVicarious Surgical receives NYSE delisting noticeMarch 4, 2026 | medtechdive.comMVicarious Surgical Confronted with NYSE Delisting Amid Ongoing ChallengesMarch 4, 2026 | mddionline.comMVicarious Surgical Receives Delisting Notice From NYSEMarch 4, 2026 | finance.yahoo.comVicarious Surgical faces NYSE delisting againMarch 4, 2026 | massdevice.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 20263 Energy Stocks to Buy and 2 to Avoid as AI Power Demand ExplodesBy Bridget Bennett | May 4, 2026Alphabet’s Earnings Didn’t Just Beat—They Changed the StoryBy Ryan Hasson | April 30, 2026Intuit's Great SaaS Reset: Fired By AIBy Jeffrey Neal Johnson | May 22, 2026AVGR, RBOT, CLGN, and HSCS Company DescriptionsAvinger NASDAQ:AVGRAvinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.CollPlant Biotechnologies NASDAQ:CLGN$0.42 -0.01 (-2.67%) As of 03:37 PM EasternCollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.HeartSciences NASDAQ:HSCS$1.93 -0.05 (-2.53%) As of 04:00 PM EasternHeart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Vicarious Surgical NYSE:RBOT$0.96 -0.03 (-3.31%) As of 02:50 PM EasternVicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AutoZone's Pullback Sets Up a Long-Term Buying Opportunity AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus Powerhouse Williams-Sonoma Heading to Fresh Highs in 2026 Quantum Stocks Just Got a Lifeline—Who Benefits Most? Why BJ’s Wholesale Club Stock Could Be Ready for a Rebound 5 High-Yield Stocks and ETFs to Buy and Hold for the Next Decade Rocket Companies Turns Around, But Mortgage Risk Remains After NVIDIA, Broadcom's Earnings Are Next—Here's What to Watch Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
